Milacron IPO Exceeds $265M
Underwriters of Milacron Holdings Corp.’s initial public offering (IPO) of 14,285,714 shares of common stock, which closed on June 30, have partially exercised their over-allotment option to purchase an additional 415,600 shares. The issuance and sale of these additional “Greenshoe” shares closed on July 29. Milacron is a Cincinnati, Ohio-based industrial technology company serving the plastics processing industry.
The Greenshoe increases the net proceeds to Milacron from its IPO, after underwriting discounts and commissions and estimated offering expenses, from approximately $265 million to approximately $273 million. It intends to use the net proceeds for general corporate purposes. The net proceeds from the IPO were used to repay $248 million of the company’s term loan facility and the outstanding balance of $14.1 million under the company’s asset-based revolving credit facility. Milacrons common stock began trading on the New York Stock Exchange on June 25 under the ticker symbol “MCRN” at $20 per share. BofA Merrill Lynch, Barclays, J.P. Morgan, Baird, Credit Suisse and Goldman, Sachs & Co. acted as joint book-running managers of the offering, and KeyBanc Capital Markets and William Blair acted as co-managers.
For more information, visit www.milacron.com.